event,time
Here is the extracted table of clinical events and timestamps:,
born ,-8760.0
caesarean section ,-8760.0
birth weight 2100 g ,-8760.0
birth length 48 cm ,-8760.0
Apgar scale 8 points ,-8760.0
prominent forehead ,-8760.0
relative macrocephaly ,-8760.0
limb asymmetry ,-8760.0
5th finger clinodactyly ,-8760.0
2/3 toe syndactyly ,-8760.0
genetic examination ,-489.0
hypomethylation of the 11p15 region ,-489.0
diagnosis of SRS ,-489.0
delayed motor development ,-336.0
walked independently ,-336.0
hepatic dysfunction ,-420.0
increased AlAT ,-420.0
increased AspAT ,-420.0
increased creatine kinase ,-420.0
diagnosis of DMD ,-336.0
genetic test ,-336.0
mutation of the maternal DMD gene ,-336.0
corticosteroids treatment ,-192.0
prednisone treatment ,-192.0
deflazacort treatment ,-96.0
G-CSF treatment ,-72.0
sepsis ,-72.0
hypoglycaemia ,-72.0
neurological symptoms ,-72.0
glucose level 14 mg/dl ,-72.0
urological care ,-72.0
hypospadias ,-72.0
cardiological diagnostics ,-12.0
sinus tachycardia ,-12.0
heart murmur ,-12.0
propranolol treatment ,-12.0
growth hormone deficiency ,0.0
rhGH treatment ,0.0
height 115.9 cm ,0.0
weight 19.9 kg ,0.0
BMI 14.8 kg/m2 ,0.0
target height 182.5 cm ,0.0
height velocity 4.3 cm/year ,0.0
glucose and insulin levels ,0.0
IGF-1 and IGFBP-3 concentrations ,0.0
MRI of the hypothalamic-pituitary region ,0.0
transparent septum cyst ,0.0
rhGH therapy started ,0.0
height velocity increased ,12.0
IGF-1 level increased ,12.0
BMI increased ,12.0
glucose metabolism worsened ,12.0
insulin resistance ,12.0
HbA1c elevated ,12.0
6MWT distance decreased ,12.0
abnormal gait ,12.0
rhGH dose reduced ,12.0
behavioural treatment ,12.0
lifestyle modification ,12.0
rhGH therapy discontinued ,18.0
densitometry performed ,18.0
body mass composition examined ,18.0
bone density test ,18.0
Z-score -2.2 ,18.0
